|
HS Code |
480373 |
As an accredited 2-Hydroxybenzimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Hydroxybenzimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In labs and production sites across the world, the search for reliable heterocyclic compounds remains a daily part of research and industry. Among these, 2-Hydroxybenzimidazole stands out as more than just a link in a supply chain—it opens the door to new chemistry for many teams. My experience with this compound has brought to light its remarkable stability and value in applications that call for both precision and dependability.
2-Hydroxybenzimidazole carries the molecular formula C7H6N2O and often appears as a pale, crystalline powder. Its chemical structure, placing a hydroxyl group on the benzimidazole ring, gives it a character distinct from the unsubstituted benzimidazole. That extra functional group can determine the path of an entire synthesis, letting downstream chemistry access new possibilities. The ability to tweak physical or electronic properties with such simple modifications is one of the joys of organic chemistry, and 2-Hydroxybenzimidazole shows up just where a little extra control is required.
Medicinal chemists see this compound as an intermediate with significant promise. Its unique skeleton, combined with that hydroxyl side, means it pops up in literature for synthesizing pharmaceutical agents with biological activity. Antimicrobial, antiviral, or anticancer research often passes through a benzimidazole stage. If you’ve spent time in a synthetic chemistry lab, you might have found yourself grateful for how clean this compound recrystallizes and how easily it integrates into multi-step syntheses without losing structural integrity. No small feat when a reaction pathway can teeter off course at any moment.
Beyond pharmaceuticals, 2-Hydroxybenzimidazole matters in dye development, corrosion inhibitors, and as a ligand for coordination chemistry. The practical upshot is that it helps materials scientists and industrial chemists push their studies further, whether that's in building complex molecular assemblies or preventing rust in metal processing plants. This compound’s stability, both chemically and thermally, makes it valuable for any process that will see harsh conditions or lengthy storage. It doesn’t break down or lose its punch simply from sitting on a shelf or getting tossed between flasks—something every lab tech can appreciate.
When talking about models, most users refer to the compound’s grade and purity. In many cases, you’ll see high-performance liquid chromatography (HPLC) confirming a purity over 98%. That number means a lot for researchers. In my years managing lab inventories, I’ve noticed time and again that the small percentage points between a “research grade” bottle and a lower-purity alternative save headaches during analytics. Side reactions fall off, clean spectra make analysis straightforward, and you spend less time troubleshooting unexplained results. Many suppliers offer batches ranging from small amber glass vials for R&D to multikilogram drums for industrial use, giving flexibility based on demand.
Physical specs highlight that 2-Hydroxybenzimidazole doesn’t attract too much moisture, stores well under standard cool, dry conditions, and dissolves readily in common polar solvents like DMSO and ethanol. This keeps handling simple, and means you don’t fight with solubility during downstream transformations or assays. I’ve worked with compounds that gunk up equipment or demand oddball solvents—this isn’t one of them. That practical ease carries over no matter which brand or model ends up on your shelf.
Look at benzimidazoles with different functional groups, and you’ll notice how the position and type of substituent drive reactivity and selectivity. Take 2-hydroxy versus 1-hydroxy or non-hydroxylated forms: that difference, slight by the standards of structural diagrams, can reshape biological activity and selectivity in drug leads. My work on kinase inhibitor analogues proved this point firsthand, where shifting a single group altered the reaction kinetics and downstream pharmacology. For folks developing coatings or dyes, small variations in the aromatic nucleus make all the difference in lightfastness and solubility.
Some try 2-aminobenzimidazole or benzimidazole-5-carboxylic acid as alternatives, betting on related reactivity or binding affinity. These can fill similar roles, but the hydroxyl group’s hydrogen-bonding capacity and nucleophilic tendencies give 2-Hydroxybenzimidazole a leg up in certain coupling reactions or chelation. I’ve seen this matter most in ligand work, where you want to wrangle metal ions for catalysis or complex building. Where another benzimidazole might fall short, this version steps up and bridges coordination sites smoothly, often improving yields and selectivity for downstream products.
Juggling shelf life, batch consistency, and regulatory thresholds, buyers and users face clear choices about which benzimidazole derivative to keep on hand. I’ve run into corners where purity slips and analytical results get fuzzy—often traced back to low-quality material brought in to cut costs. With 2-Hydroxybenzimidazole, cGMP-grade lots and certificates of analysis can make or break compliance in pharmaceutical workflows. Having an unambiguous analytical profile isn’t just red tape; it smooths out supply chains and keeps regulatory inspectors off your back. Teams that skimp on documentation or traceability soon see the cost in recalls or failed audits.
Another factor is safe handling. While 2-Hydroxybenzimidazole doesn’t bring the acute risks of volatile organic compounds or bulk corrosives, it calls for reasonable lab safety. Dust masks and gloves suffice in most settings, with disposal following standard organic waste streams to avoid environmental release. I’ve found that clear protocols and training—especially for interns or casual users—reduce accidents and keep the workflow efficient. The low odor and predictable melting range reduce the drama often linked to more volatile heterocycles.
The rush toward new therapeutics and advanced materials keeps demand for high-quality intermediates high. In my time supporting pharmaceutical developers, I’ve watched 2-Hydroxybenzimidazole anchor more than a handful of research breakthroughs. Whether it’s serving as a building block for enzyme inhibitors or as a stabilizer in anti-corrosive coatings, the practical value shows up in outcomes, not just batch records. Research teams often share case studies highlighting successful scale-ups, citing robust yields and minimal troubleshooting. Knowing a compound will “work as advertised” frees both bench chemists and decision-makers to focus on innovation instead of technical fires.
Material sustainability has become a key concern, especially as regulations tighten. Many older compounds fail to meet modern safety or environmental rules, but 2-Hydroxybenzimidazole aligns well with these expectations. Low toxicity, clean decomposition, and absence of heavy metals mean fewer barriers for approval and less long-term environmental risk. In my own sustainability initiatives, switching to cleaner intermediates often granted easier passage through internal review and community scrutiny.
The constant need for better ligands and novel pharmacophores makes compounds like this hard to replace. Chemists at the bench and in management both want tools that perform without expensive side effects—literally or figuratively. As green chemistry pushes for milder conditions and safer workflows, 2-Hydroxybenzimidazole’s moderate reactivity shines. It opens the door to one-pot syntheses and catalyst recycling, streamlining efforts in both exploratory and production settings. I’ve collaborated with synthesis teams who use it to cut cycle times and waste, all while hitting tighter purity specifications needed for advanced pharmaceuticals and diagnostics.
It doesn’t hurt that the supply chain for 2-Hydroxybenzimidazole has matured. Reliable vendors deliver consistent batches. Supply disruptions remain rare compared to niche heterocycles or those requiring costly starting materials. In my experience, this reduces project risk and keeps process optimization focused on real performance gains—not paperwork or procurement headaches. The straightforward synthesis, often starting from o-phenylenediamine and salicylic acid, shortens lead times and keeps costs in check.
One of the main reasons I continue to recommend 2-Hydroxybenzimidazole is how it scales from the bench to pilot plant. I’ve watched it move through the R&D pipeline, scale up in 100-gram test runs, and land in kilogram-scale reactors without demanding a rewrite of protocols or workflows. That kind of flexibility makes life easier for chemical engineers as well as laboratory scientists. Variable reaction parameters don’t throw it off track, and both standard glassware and automated processes churn out product with minimal hiccups.
For quality control teams, routine analytical methods such as NMR, IR, and HPLC provide clear fingerprints for both identification and purity checks. The compound behaves predictably during assessment, removing the guesswork that often drags out batch release or blocks shipments to clients. Having spent years bridging R&D labs and production, I’ve seen such properties take the sting out of scale-ups and repeated syntheses, which often catch less robust intermediates by surprise. That predictability saves both time and money, two resources always in short supply in weighty projects.
Developers focused on small molecule drugs keep returning to this intermediate. Its role in antiviral agents and kinase inhibitors crops up throughout patent databases and research articles. Given rampant infectious disease and pressing oncology needs, having dependable intermediates speeds up preclinical testing. In my discussions with process chemists, reliable payload handlers and consistent conversion rates often mean fewer headaches, less batch reprocessing, and tighter regulatory circles. Formulation scientists also appreciate the compound’s moderate logP and favorable pKa, which can ease the path to acceptable bioavailability for finished drugs.
Interest in green and biocompatible molecules puts pressure on companies to review their ingredient choices. 2-Hydroxybenzimidazole’s benign profile and compatibility with aqueous synthesis routes have helped answer calls for cleaner, safer products. I’ve witnessed pharma partners win internal approval on new drug candidates partly by pointing to intermediates that don’t trigger regulatory pushback. The smoother journey from discovery to development keeps companies agile and nimble as they bring therapies to a demanding global market.
Beyond health and medicine, application areas for 2-Hydroxybenzimidazole continue expanding. Researchers pushing boundaries in optical materials, polymers, and corrosion science tap its unique binding and electronic properties. In dye chemistry, it gives bright, consistent hues and holds up under adverse lighting or chemical conditions. Many projects I’ve shadowed in industrial chemistry focused on metal plating or surface treatments cite the value of heterocycles in achieving uniform, robust coatings. That tiny structural twist—the hydroxyl—nudges metal ions into place, making the difference between a promising prototype and a failed commercial product.
Complexation chemistry also benefits from this molecule. Scientists assembling catalysts or metal-organic frameworks appreciate ligands that deliver both electronic flexibility and geometric fit. My own time in a catalysis lab drove home the value of reliable ligands: fewer purification steps, robust activity, and faster cycles. Time spent optimizing these systems doesn’t disappear chasing analytic ghosts or off-target reactions, letting teams drive innovations where they’re needed most. Industrial clients across coatings, electronics, and materials science echo the same priorities—outcomes tied to reproducible, well-characterized components.
Modern chemical practice hinges on sustainability and risk reduction as much as on cost savings. Lab leaders and production managers must now weigh more than just reactivity—they balance lifecycle, end-of-life, and supply assurance considerations. 2-Hydroxybenzimidazole stands up well when measured against these imperatives. It avoids some of the hazards that tar legacy intermediates with regulatory red flags. Low volatility, manageable toxicity, and a clear path for controlled disposal reduce both incident risk and long-term liability. That’s not just a compliance issue—it’s about building trust with internal stakeholders and external customers alike.
Instituting more sustainable chemistry has called for practical decisions. Teams looking to shrink their environmental footprint have replaced more hazardous benzimidazole derivatives with 2-hydroxy variants, realizing improvements not only in regulatory scores but also job satisfaction and morale. I’ve seen these shifts translate into streamlined workflows, smoother interactions with regulatory agencies, and faster product launches, all while maintaining the technical quality needed for brand protection and end-user safety.
Chemistry doesn’t stand still, and neither does the investigation of derivatives like 2-Hydroxybenzimidazole. Current academic research explores new pharmaceutical leads, photostable dyes, and chelation techniques built on this backbone. Each year brings fresh methods for functionalization and new examples of bioactivity, reinforcing the role of benzimidazoles as privileged scaffolds in chemical discovery. Industrial collaborations with academic partners often focus on applications that square the circle: high performance, low risk, and scalable supply chains. The consistent performance of 2-Hydroxybenzimidazole in these contexts keeps it on the shortlists of both old-school chemists and next-generation innovators.
The next decade may yet reveal new fields where benzimidazole derivatives help solve global challenges. Advances in personalized medicine, safer materials for electronics, and environmental remediation continue to draw on the compound’s flexible chemistry and clean safety record. Drawing from my experience sitting in project planning meetings, a reliable, general-purpose intermediate never loses value. Teams equipped with solid starting points can shift gears as project goals evolve, meeting the demands of customers, regulators, and end users alike.
Reflecting on the journey of 2-Hydroxybenzimidazole from a niche academic interest to a practical mainstay in research and industrial labs, one lesson stands out—dependability matters just as much as innovation. When a compound offers both, it earns a lasting place in the chemical toolbox. Its ability to provide consistent results, safe handling, and diverse utility underpins successful research and product launches across disciplines. With the pace of modern science, the ease of integrating 2-Hydroxybenzimidazole into workflows lets teams spend less time firefighting and more time creating. In the ongoing quest for better solutions in chemistry and beyond, that practical advantage stands out.